Janus Henderson Investors US’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Janus Henderson Investors US’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,270,630	Closed	-$67.9M	–	1245
2016 Q1	$67.9M	Buy	1,270,630 +198,933	+19%	+$14.7M	0.06%	356
2015 Q4	$121M	Buy	1,071,697 +58,323	+6%	+$6.43M	0.1%	250
2015 Q3	$119M	Sell	1,013,374 -588,848	-37%	-$76.9M	0.11%	236
2015 Q2	$124M	Buy	1,602,222 +1,187,191	+286%	+$77.8M	0.1%	267
2015 Q1	$24M	Buy	+415,031	New	+$17.6M	0.02%	584

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Janus Henderson Investors US's ANAC Position: Q2 2016 in Review

Janus Henderson Investors US sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,270,630 shares — an estimated $67.9M sold.

Janus Henderson Investors US first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $124M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Janus Henderson Investors US reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Janus Henderson Investors US sold 1,270,630 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $67.9M.
Janus Henderson Investors US first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
Janus Henderson Investors US's ANACOR PHARMACEUTICALS INC COM position peaked at $124M in Q2 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Janus Henderson Investors US's 13F filing for Q2 2016, filed 12 Aug 2016.